Avenue Therapeutics, Inc.
(NASDAQ : ATXI)

( )
Volume Open Day's Low Day's High 52 Wk Low 52 Wk High Bid Ask EPS PE Ratio Shares Market Cap Dividend Ex-Div Date Yield
Do You Like Swing Trading?
Learn how we win with easy 3-5 day holds.
Be 'active' in the market while NOT being tied to your desk.
100% secure: your email is never shared, and you may opt out at any time.
...
Health Technology » Pharmaceuticals Major
symbolcompany%chnglast%shortavg$volume
JNJJohnson & Johnson
-10.17%132.810.6%$1507.80m
PFEPfizer Inc.
-1.62%43.850.9%$1018.02m
MRKMerck & Co., Inc.
-2.49%76.510.6%$1010.61m
ABBVAbbVie, Inc.
-2.38%85.622.2%$531.70m
LLYEli Lilly and Company
-2.49%112.001.0%$505.80m
BMYBristol-Myers Squibb Company
-2.82%52.131.4%$488.82m
NVSNovartis AG Sponsored ADR
-1.13%87.400.2%$229.97m
AZNAstraZeneca PLC Sponsored ADR
-0.20%39.161.3%$204.11m
GSKGlaxoSmithKline plc Sponsored ADR
-0.87%37.610.2%$157.71m
NVONovo Nordisk A/S Sponsored ADR Class B
-0.51%46.530.1%$72.80m
SNYSanofi Sponsored ADR
-1.83%44.070.2%$46.08m
LCILannett Company, Inc.
-4.53%4.8537.0%$8.90m
AKTXAkari Therapeutics Plc Sponsored ADR
4.12%1.771.7%$0.02m

Company Profile

Avenue Therapeutics, Inc. operates as a pharmaceutical company. It engages in acquiring, licensing, developing, and commercializing products for use in the intensive care hospital setting. The company was founded on February 9, 2015 and is headquartered in New York, NY.